Select a State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Michigan

Medicaid is seeking new applicants to serve on its newly reimagined Medicaid Advisory Committee (MAC). Specifically, they are encouraging individuals who have experience with Medicaid as an advocate, community leader or direct service provider to apply. 

Applications will be accepted until 5:00 pm on August 8. Visit the Online Application to learn more and apply. Questions can be directed to MDHHS-MAC@michigan.gov.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-07-31T15:01:34-04:00July 31, 2025|Michigan|

Michigan

Medicaid has announced that, effective October 1, pharmacy providers must enroll in electronic funds transfer (EFT) to receive fee-for-service pharmacy payments. After this date, paper checks will no longer be issued for pharmacy payments. This change is intended to address issues such as lost checks, payment delays and mailing time, as well as to modify payment security protocols. Providers that still need to enroll in EFT will need to first register with the Prime User Administration Console (UAC). See the UAC Quick Start Guide for step-by-step instructions on the registration process. Once registered, you will have access to the Provider Job Aid/Prime Therapeutics Financial Portal Guide which will provide step-by-step instructions on completing the EFT enrollment process. After submitting your enrollment request, you will receive a phone call within three business days to verify the information you provided. Please make every effort to complete this verification as soon as possible once contacted to avoid any delays in finalizing your enrollment. Questions should be directed to the Prime Therapeutics Provider Support Line at 1-888-277-5510, OPTION 1. 

Also in Michigan, Medicaid announced via email that effective August 1, the following brand products will no longer be preferred and will be replaced by their generic alternatives on the preferred drug list (PDL). An updated Brand over Generic List will be posted soon. 

  • Pradaxa® (dabigatran etexilate) 
  • Humalog Mix pen (insulin lispro protamine) 
  • Novolog cartridge (insulin aspart) 

 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-07-11T09:07:16-04:00July 11, 2025|Michigan|

Michigan

The Department of Health and Human Services will be conducting CHAMPS System maintenance this weekend. As a result, the system will not be available between 6:00 pm EST on November 16 through 9:00 am EST on November 17, 2024. Providers with questions should contact Provider Support at 1-800-292-2550 or ProviderSupport@Michigan.gov.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-11-14T10:40:38-05:00November 14, 2024|Michigan|

Michigan

The Board of Pharmacy posted a notice and agenda for a Rules Committee Workgroup on November 4. Instructions for attending the meeting are included in the notice.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-10-10T11:32:47-04:00October 10, 2024|Michigan|

Michigan

Sen. Santana has introduced SB 993,  a “trailer” bill that require insurers to reimburse pharmacies for the vaccination and test and treat services authorized under P.A. 97 of 2023. The bill was referred to the Senate Health Policy Committee and could see action as early as this fall.

Also in Michigan, the Department of Health, and Human Services (MDHHS) has issued a final bulletin ending three temporary COVID-19 Medicaid Pharmacy provisions due to the COVID-19 PHE.

  • HASA 22-02 – Authorization of U.S. Food & Drug Administration (FDA) Emergency Use Authorization (EUA) pharmacist prescriptive authority of oral antivirals for the treatment of COVID-19;
  • MMP 22-29 – Coverage of FDA EUA COVID-19 monoclonal antibody injections by pharmacy providers; and
  • L 22-04 – Stand-alone vaccine counseling services billed as a Medication Therapy Management service.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-09-19T10:48:17-04:00September 19, 2024|Michigan|

Michigan

The Department of Health and Human Services issued a final bulletin related to the end of COVID flexibilities for OTC (Over-the-Counter) COVID tests and pharmacies as labs.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-09-05T09:56:38-04:00September 5, 2024|Michigan|
Go to Top